OmniSpectra Completes Development of Silicon Photonics Optical Defect Inspection Platform, Equipment Validation to Conclude by Year-End

OmniSpectra (7728-TW) announced today (30th) that it has completed the development of Night Jar-H, its silicon photonics optical defect inspection system tailored for mass production requirements. The company has already completed Proof of Technology (PoT) validation with leading international manufacturers and will now proceed with High Volume Manufacturing (HVM) validation to assess the feasibility of integrating the system into actual production processes and high-volume manufacturing environments. Equipment validation is expected to be completed by the end of this year.

Spokesperson Liao Qing-Lin stated that OmniSpectra’s equipment validation is progressing steadily, with partners simultaneously planning subsequent HVM validation activities. The scope of validation is gradually expanding from equipment functionality to evaluating integration into mass production workflows and manufacturing processes. The company remains optimistic about future developments.

OmniSpectra further explained that HVM validation is a critical phase in determining whether a technology can be successfully introduced into mass production. Beyond confirming equipment functionality, it is essential to verify integration with existing manufacturing processes, measurement efficiency, operational stability, and actual contributions to yield management. In the semiconductor industry, the key metric for any new technology is its ability to stably integrate into mass production lines. Therefore, HVM validation represents a crucial milestone in transitioning from Engineering Validation to mass production deployment.

As silicon photonics chips enter mass production, efficient optical defect detection and yield management have become common industry challenges. Night Jar-H can screen out high-risk dies (Risky Die) during the production process, helping to reduce overall measurement time and potentially addressing one of the key yield issues in current CPO mass production—SiN (silicon nitride) yield.

OmniSpectra noted that silicon photonics inspection technology is transitioning from engineering validation to mass production between 2026 and 2027. Throughout this process, challenges related to system integration and validation have been progressively overcome. The company is now actively preparing related production capacity and plans to break ground on a new factory by the end of the year to meet future demand.

Liao Qing-Lin explained that OmniSpectra is neither an IC design company nor a wafer foundry but positions itself as an AI-driven Optical Manufacturing Intelligence Platform. By leveraging optical imaging, AI, and manufacturing data analytics, the company assists the silicon photonics industry in improving yield management efficiency, reducing test costs, and accelerating mass production deployment. Its services span the entire supply chain, including design, manufacturing, packaging, and testing.

OmniSpectra stated that both the Night Jar and Night Jar-H production models are architecturally capable of supporting two key pathways: CPO (Co-Packaged Optics) and NPO (Near-Packaged Optics), the latter of which has recently gained significant market attention. The technological roadmap for silicon photonics packaging architectures is still evolving, and regardless of whether the industry adopts CPO or NPO in the near term, OmniSpectra’s inspection technology can meet the associated detection requirements.

OmniSpectra reported cumulative revenue of NT$208 million in the first half of 2026, representing a year-on-year increase of 27.01%. June’s monthly revenue reached NT$53.6 million, up 114.18% year-on-year—the highest monthly revenue in the past year. The company remains optimistic about its outlook for the third quarter.